Finepoint Capital

Finepoint Capital as of Sept. 30, 2023

Portfolio Holdings for Finepoint Capital

Finepoint Capital holds 30 positions in its portfolio as reported in the September 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Moonlake Immunotherapeutics Class A Ord (MLTX) 9.4 $19M 331k 57.00
Amicus Therapeutics (FOLD) 9.0 $18M 1.5M 12.16
Sarepta Therapeutics (SRPT) 8.8 $18M 145k 121.22
Prothena Corp SHS (PRTA) 8.4 $17M 349k 48.25
Galapagos Nv Spon Adr (GLPG) 7.9 $16M 459k 34.55
Ascendis Pharma A/s Sponsored Adr (ASND) 7.6 $15M 164k 93.64
Springworks Therapeutics (SWTX) 6.4 $13M 557k 23.12
Cytokinetics Com New (CYTK) 6.3 $13M 432k 29.46
Cerevel Therapeutics Hldng I (CERE) 6.1 $12M 563k 21.83
Revolution Medicines (RVMD) 5.9 $12M 427k 27.68
ACADIA Pharmaceuticals (ACAD) 5.8 $12M 557k 20.84
Arvinas Ord (ARVN) 4.9 $9.9M 505k 19.64
Travere Therapeutics (TVTX) 4.0 $8.0M 896k 8.94
Morphic Hldg (MORF) 3.7 $7.5M 325k 22.91
Relay Therapeutics (RLAY) 3.6 $7.3M 871k 8.41
Solid Biosciences Com New (SLDB) 1.2 $2.4M 961k 2.52
Calidi Biotherapeutics Com New (CLDI) 0.2 $416k 125k 3.33
Ares Acquisition Corp *w Exp 02/02/202 0.2 $334k 505k 0.66
Bridgetown Holdings *w Exp 09/30/202 0.2 $304k 895k 0.34
Churchill Capital Corp Vii *w Exp 02/29/202 (CVIIW) 0.1 $169k 548k 0.31
Calidi Biotherapeutics *w Exp 03/14/202 (CLDI.WS) 0.1 $144k 655k 0.22
Compass Digital Acquisition Corp *w Exp 09/29/202 (CDAQW) 0.1 $101k 460k 0.22
Churchill Capital Corp Vi *w Exp 02/17/202 0.0 $86k 540k 0.16
Ross Acquisition Corp Ii *w Exp 02/01/202 0.0 $49k 440k 0.11
Concord Acquisition Corp Ii *w Exp 99/99/999 (CNDA.WS) 0.0 $43k 408k 0.10
Swiftmerge Acquisition Corp *w Exp 12/13/202 (IVCPW) 0.0 $35k 490k 0.07
Ys Biopharma *w Exp 03/15/202 (YSBPW) 0.0 $17k 490k 0.04
Marblegate Acquisition Corp *w Exp 08/31/202 (GATEW) 0.0 $14k 735k 0.02
Churchill Capital Corp V *w Exp 10/29/202 0.0 $0 612k 0.00
Home Plate Acquisition Corp *w Exp 09/30/202 0.0 $0 690k 0.00